Ardent Health Partners, LLC beat EPS estimates 67% of the time across 9 reported quarters (6 beats, 3 misses), averaging +21.9% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.17 | $0.12 | -29.4% | Miss | |
| Q1 FY26 | $0.18 | $0.28 | +55.6% | Beat | |
| Q4 FY25 | $0.35 | $0.32 | -8.6% | Miss | |
| Q3 FY25 | $0.42 | $0.52 | +23.8% | Beat | |
| Q2 FY25 | $0.30 | $0.52 | +73.3% | Beat | |
| Q1 FY25 | $0.21 | $0.29 | +38.1% | Beat | |
| Q4 FY24 | $0.50 | $0.81 | +62.0% | Beat | |
| Q3 FY24 | $0.29 | $0.19 | -34.5% | Miss | |
| Q2 FY24 | $0.30 | $0.35 | +16.7% | Beat |
Back to ARDT overview · ARDT holders · ARDT KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.